Disability Rights debated at Prime Ministers Questions
Jeremy Corbyn, Labour Leader put the disability rights questions to the Prime Minister Theresa May on December 5 2018 during the latest session of Prime Ministers Questions.
Read more-
Update on UNITE-DMD gene therapy trial
18/10/2018Work has begun in Professor George Dickson’s lab to refine the gene therapy product.
-
CMT gene therapy trial to start in 2019
15/10/2018Sarepta Therapeutics has announced that it will be working with Dr Zarife Sahenk from Nationwide Children’s Hospital in the United States to develop a gene therapy for CMT.
-
Trailblazers attend Loughborough University Hackathon
15/10/2018On September 27th Trailblazers attended the Global Disability Innovation Hub event “Hacking Disability – How do you change a lightbulb if you use a wheelchair?” Loughborough U
-
Countdown to the MDUK Championship Powerchair Football season
11/10/2018MDUK Championship Powerchair Football starts Saturday
-
UK Independent Mechanism updates UN on Disabled Peoples Rights
11/10/2018The United Nations Committee on the Rights of Persons with Disabilities held a review into the state of accessibility and inclusion in 2017, and this report updates the committee.
-
Gabby Logan appointed new President of Muscular Dystrophy UK
10/10/2018British presenter and former Welsh international gymnast Gabby Logan is to be the new President of Muscular Dystrophy UK.
-
New ultra-orphan pathway in Scotland
08/10/2018The Scottish Government have announced details about a new ultra-orphan pathway
-
PTC announces long-term data on Duchenne drug
08/10/2018PTC Therapeutics recently presented positive preliminary data on the long-term clinical benefit of Translarna at the World Muscle Society conference.
-
Becker Awareness Week 2018
07/10/2018Becker Awareness Week 2018 runs from 7 October to 13 October, and is a chance for us all to show our support and help people understand the condition.
-
Update from X-MTM gene therapy trial
05/10/2018Today at the World Muscle Society conference, Audentes Therapeutics announced new data from its ASPIRO study testing a gene therapy for X-linked myotubular myopathy.